Mirum Pharmaceuticals Inc. (MIRM) NASDAQ

$24.17 0.36 (1.51%)

Market Cap: $1.12B

As of 04/22/24 04:00 PM EDT. Market closed.

(MIRM)

Mirum Pharmaceuticals Inc. (MIRM)
NASDAQ

$24.17
0.36 (1.51%)

Market Cap: $1.12B

As of 04/22/24 04:00 PM EDT. Market closed.

Add to Portfolio

mirum pharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. its lead product candidate is maralixibat, an investigational oral drug that is in phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
198
Address
.
PRICE CHART FOR MIRUM PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$23.85
Previous Close
$23.81
Days Range
$23.40 - $23.98
52 week range
$23.29 - $35.56
Volume
254,735
Avg. Volume (30 days)
439,446
Market Cap
$1.12B
Dividend Yield
-
P/E
(6.85)
Shares Outstanding
47,003,329
Open
$23.85
Previous Close
$23.81
Days Range
$23.40 - $23.98
52 week range
$23.29 - $35.56
Volume
254,735
Avg. Volume (30 days)
439,446
Market Cap
$1.12B
Dividend Yield
-
P/E
(6.85)
Shares Outstanding
47,003,329
FINANCIAL STATEMENTS FOR MIRUM PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MIRUM PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
BJERKHOLT ERICCHIEF FINANCIAL OFFICERMar 27, 2024 Buy$24.802,00049,60014,000Mar 27, 2024, 08:47 PM
Radovich PeterPRESIDENT AND COOMar 25, 2024 Sale$25.804,303111,01729,013Mar 25, 2024, 05:41 PM
Radovich PeterPRESIDENT AND COOJan 09, 2023 Sale$20.621,37928,43833,316Mar 18, 2024, 05:46 PM
Vig PamelaCHIEF SCIENTIFIC OFFICERJan 09, 2023 Sale$20.621,37928,43827,312Mar 18, 2024, 05:44 PM
Longpre LaraCHIEF DEVELOPMENT OFFICERSep 10, 2019 Buy$10.6496510,268105,372Mar 18, 2024, 05:40 PM
Longpre LaraCHIEF DEVELOPMENT OFFICERJan 09, 2023 Sale$20.621,00320,684104,369Mar 18, 2024, 05:40 PM
Peetz ChristopherCHIEF EXECUTIVE OFFICERJan 09, 2023 Sale$20.625,159106,39091,953Mar 18, 2024, 05:37 PM
BJERKHOLT ERICCHIEF FINANCIAL OFFICERMar 18, 2024 Buy$25.802,00051,60012,000Mar 18, 2024, 05:34 PM
Vig PamelaCHIEF SCIENTIFIC OFFICERFeb 02, 2024 Sale$26.191,21431,79728,691Feb 05, 2024, 09:12 PM
Longpre LaraCHIEF DEVELOPMENT OFFICERFeb 02, 2024 Sale$26.1984722,184104,407Feb 05, 2024, 09:10 PM
Radovich PeterPRESIDENT AND COOFeb 02, 2024 Sale$26.191,79046,88334,695Feb 05, 2024, 09:05 PM
Peetz ChristopherCHIEF EXECUTIVE OFFICERFeb 02, 2024 Sale$26.196,013157,491104,112Feb 05, 2024, 09:04 PM
Howe JolandaSVP, GLOBAL CONTROLLERFeb 02, 2024 Sale$26.1973519,2511,759Feb 02, 2024, 09:28 PM
Radovich PeterCHIEF OPERATING OFFICERJan 08, 2024 Sale$28.031,40839,47336,485Jan 09, 2024, 08:28 PM
Longpre LaraCHIEF DEVELOPMENT OFFICERJan 08, 2024 Sale$28.031,01928,568105,254Jan 09, 2024, 08:25 PM
Vig PamelaHEAD OF RESEARCH & DEVELOPMENTJan 08, 2024 Sale$28.031,40839,47229,905Jan 09, 2024, 08:21 PM
Peetz ChristopherPRESIDENT AND CEOJan 08, 2024 Sale$28.035,209146,033110,125Jan 09, 2024, 08:12 PM
Howe JolandaSVP, GLOBAL CONTROLLERJan 08, 2024 Sale$28.0452814,803722Jan 09, 2024, 08:09 PM
Howe JolandaSVP, Global ControllerDec 05, 2023 Option Exercise$2.942,5007,3502,500Dec 06, 2023, 05:16 PM
Howe JolandaSVP, Global ControllerDec 05, 2023 Sale$32.402,50081,0000Dec 06, 2023, 05:16 PM
Vig PamelaHead of Research & DevelopmentNov 10, 2023 Option Exercise$22.2952711,74531,313Nov 15, 2023, 08:14 PM
Longpre LaraChief Development OfficerNov 10, 2023 Option Exercise$22.294349,673106,273Nov 15, 2023, 08:13 PM
Radovich PeterChief Operating OfficerNov 10, 2023 Option Exercise$22.292184,85937,893Nov 15, 2023, 08:11 PM
Heron Patrick JDirectorNov 09, 2023 Buy$28.302,91082,353161,963Nov 14, 2023, 04:35 PM
Heron Patrick JDirectorSep 13, 2023 Buy$31.022,62581,425159,053Sep 15, 2023, 04:56 PM
GREY MICHAEL GDirectorSep 14, 2023 Option Exercise$2.9414,21641,73814,216Sep 14, 2023, 07:33 PM
GREY MICHAEL GDirectorSep 13, 2023 Option Exercise$2.943921,151392Sep 14, 2023, 07:33 PM
GREY MICHAEL GDirectorSep 14, 2023 Sale$32.0014,216454,9120Sep 14, 2023, 07:33 PM
GREY MICHAEL GDirectorSep 13, 2023 Sale$32.0039212,5440Sep 14, 2023, 07:33 PM
BJERKHOLT ERICChief Financial OfficerSep 11, 2023 Buy$29.6510,000296,49210,000Sep 12, 2023, 06:23 PM
Heron Patrick JDirectorAug 31, 2023 Buy$26.25147,9913,884,764147,991Sep 05, 2023, 12:51 PM
Howe JolandaSVP, Global ControllerAug 25, 2023 Sale$26.233,45990,7430Aug 28, 2023, 04:30 PM
Radovich PeterChief Operating OfficerJul 03, 2023 Sale$25.651,42536,54637,675Jul 05, 2023, 07:47 PM
Longpre LaraChief Development OfficerJul 03, 2023 Sale$25.651,00425,749105,839Jul 05, 2023, 07:37 PM
Vig PamelaHead of Research & DevelopmentJul 03, 2023 Sale$25.651,42536,54630,786Jul 05, 2023, 07:35 PM
Howe JolandaSVP, Global ControllerJul 03, 2023 Sale$25.6591523,4673,459Jul 05, 2023, 07:33 PM
Peetz ChristopherPresident and CEOJul 03, 2023 Sale$25.655,498141,005115,334Jul 05, 2023, 07:30 PM
GREY MICHAEL GDirectorJun 08, 2023 Option Exercise$2.9414,60842,88914,608Jun 09, 2023, 04:20 PM
GREY MICHAEL GDirectorJun 08, 2023 Sale$29.0014,608423,6320Jun 09, 2023, 04:20 PM
Vig PamelaHead of Research & DevelopmentMay 10, 2023 Option Exercise$16.9268411,57632,211May 19, 2023, 04:05 PM
GREY MICHAEL GDirectorMay 03, 2023 Option Exercise$2.9414,60842,88914,608May 04, 2023, 09:58 PM
GREY MICHAEL GDirectorMay 03, 2023 Sale$28.0014,608409,0240May 04, 2023, 09:58 PM
O'Donnell NiallDirectorNov 15, 2022 Sale$19.6993,7701,846,0221,621,118Nov 15, 2022, 08:02 PM
O'Donnell NiallDirectorNov 14, 2022 Sale$19.6032,109629,4231,714,888Nov 15, 2022, 08:02 PM
O'Donnell NiallDirectorNov 11, 2022 Sale$19.99174,1213,481,4101,746,997Nov 15, 2022, 08:02 PM
Clements IanChief Financial OfficerNov 10, 2022 Option Exercise$17.053255,54230,011Nov 14, 2022, 09:46 PM
Peetz ChristopherPresident and CEONov 10, 2022 Option Exercise$17.054983569,576Nov 14, 2022, 09:45 PM
Vig PamelaHead of Research & DevelopmentNov 10, 2022 Option Exercise$17.0566011,25421,902Nov 14, 2022, 09:43 PM
Radovich PeterChief Operating OfficerNov 10, 2022 Option Exercise$17.052924,97923,692Nov 14, 2022, 09:41 PM
Longpre LaraChief Development OfficerNov 10, 2022 Option Exercise$17.05821,39896,534Nov 14, 2022, 09:40 PM
Flynn James E10% OwnerJun 06, 2022 Sale$25.0120,212505,4601,711,324Jun 08, 2022, 07:25 PM
Flynn James E10% OwnerJun 06, 2022 Sale$25.0118,266456,7951,546,588Jun 08, 2022, 07:25 PM
Radovich PeterChief Operating OfficerMay 10, 2022 Option Exercise$13.571,16915,85923,400May 12, 2022, 09:24 PM
Longpre LaraChief Development OfficerMay 10, 2022 Option Exercise$13.571,45419,72596,452May 12, 2022, 09:23 PM
Vig PamelaHead of Research & DevelopmentMay 10, 2022 Option Exercise$13.5780710,94821,242May 12, 2022, 09:21 PM
Peetz ChristopherPresident and CEOMay 10, 2022 Option Exercise$13.571,50020,34969,527May 12, 2022, 09:17 PM
Clements IanChief Financial OfficerMay 10, 2022 Option Exercise$13.571,12515,26229,686May 12, 2022, 09:14 PM
Clements IanChief Financial OfficerNov 26, 2021 Buy$13.9075010,42518,561Nov 29, 2021, 09:49 PM
Clements IanChief Financial OfficerNov 24, 2021 Buy$14.4070010,08017,811Nov 29, 2021, 09:49 PM
Peetz ChristopherPresident and CEONov 24, 2021 Buy$14.407,000100,80028,027Nov 29, 2021, 09:47 PM
Vig PamelaChief Scientific OfficerNov 10, 2021 Option Exercise$13.5276810,38010,435Nov 15, 2021, 04:26 PM
Tucker Edwin JonathanChief Medical OfficerNov 10, 2021 Option Exercise$13.527094645,838Nov 15, 2021, 04:23 PM
Radovich PeterChief Operating OfficerNov 10, 2021 Option Exercise$13.5295812,94712,231Nov 15, 2021, 04:21 PM
Longpre LaraChief Development OfficerNov 10, 2021 Option Exercise$13.5275310,17784,998Nov 15, 2021, 04:19 PM
Clements IanChief Financial OfficerNov 10, 2021 Option Exercise$13.524586,19017,111Nov 15, 2021, 04:16 PM
Peetz ChristopherPresident and CEOOct 01, 2021 Sale$19.263,67270,70821,027Oct 01, 2021, 08:00 PM
Vig PamelaChief Scientific OfficerOct 01, 2021 Sale$19.261,36426,2659,667Oct 01, 2021, 08:00 PM
Clements IanChief Financial OfficerOct 01, 2021 Sale$19.261,57430,30916,653Oct 01, 2021, 08:00 PM
Longpre LaraChief Development OfficerOct 01, 2021 Sale$19.2696118,50584,245Oct 01, 2021, 08:00 PM
Radovich PeterChief Operating OfficerOct 01, 2021 Sale$19.261,36426,26511,273Oct 01, 2021, 08:00 PM
Tucker Edwin JonathanChief Medical OfficerOct 01, 2021 Sale$19.261,36426,26545,768Oct 01, 2021, 08:00 PM
Flynn James E10% OwnerJul 09, 2021 Sale$15.8199,3251,570,3280Jul 13, 2021, 12:06 PM
Flynn James E10% OwnerJul 07, 2021 Sale$15.876,837108,49699,325Jul 07, 2021, 06:48 PM
Flynn James E10% OwnerJul 06, 2021 Sale$16.1949,239797,426106,162Jul 07, 2021, 06:48 PM
Flynn James E10% OwnerJul 02, 2021 Sale$17.0110,599180,300155,401Jul 07, 2021, 06:48 PM
Tucker Edwin JonathanChief Medical OfficerMay 10, 2021 Option Exercise$14.621,48321,68139,007May 12, 2021, 05:46 PM
Radovich PeterChief Operating OfficerMay 10, 2021 Option Exercise$14.621,00614,7084,512May 12, 2021, 05:45 PM
Peetz ChristopherPresident and CEOMay 10, 2021 Option Exercise$14.621,45321,2432,824May 12, 2021, 05:41 PM
Longpre LaraChief Development OfficerMay 10, 2021 Option Exercise$14.621,25918,40777,081May 12, 2021, 05:38 PM
Clements IanChief Financial OfficerDec 23, 2020 Buy$18.651,59229,6917,871Mar 08, 2021, 07:42 PM
Tucker Edwin JonathanChief Medical OfficerMar 05, 2021 Option Exercise$7.701,0828,33137,524Mar 08, 2021, 06:40 PM
Tucker Edwin JonathanChief Medical OfficerDec 28, 2020 Option Exercise$7.704,16732,08636,442Dec 29, 2020, 04:24 PM
Clements IanChief Financial OfficerDec 23, 2020 Buy$18.612,47045,9757,841Dec 28, 2020, 04:12 PM
Peetz ChristopherPresident and CEODec 23, 2020 Buy$18.705,00093,480201,570Dec 28, 2020, 04:06 PM
Vig PamelaChief Scientific OfficerNov 10, 2020 Option Exercise$15.275959,0832,207Nov 12, 2020, 05:20 PM
Radovich PeterChief Operating OfficerNov 10, 2020 Option Exercise$15.2786113,1443,506Nov 12, 2020, 05:16 PM
Longpre LaraChief Development OfficerNov 10, 2020 Option Exercise$15.2782212,54975,822Nov 12, 2020, 05:14 PM
Tucker Edwin JonathanChief Medical OfficerNov 10, 2020 Option Exercise$15.271,27519,46432,275Nov 12, 2020, 05:12 PM
Clements IanChief Financial OfficerNov 10, 2020 Option Exercise$15.271,37120,9305,371Nov 12, 2020, 05:06 PM
Peetz ChristopherPresident and CEONov 10, 2020 Option Exercise$15.271,37120,9301,371Nov 12, 2020, 05:03 PM
Tucker Edwin JonathanChief Medical OfficerOct 30, 2020 Option Exercise$7.7025,000192,50031,000Nov 03, 2020, 05:09 PM
Tucker Edwin JonathanChief Medical OfficerMar 20, 2020 Buy$11.902,50029,7406,000Mar 23, 2020, 04:47 PM
Tucker Edwin JonathanChief Medical OfficerMar 19, 2020 Buy$9.912,00019,8183,500Mar 23, 2020, 04:47 PM
Fischer LaurentDirectorSep 17, 2019 Buy$9.371,64815,4356,750Sep 18, 2019, 05:23 PM
Fischer LaurentDirectorSep 16, 2019 Buy$9.474524,2805,102Sep 18, 2019, 05:23 PM
Brege LauraDirectorSep 10, 2019 Buy$11.2210,000112,20010,000Sep 12, 2019, 04:21 PM
Clements IanSVP Finance & CommunicationsSep 06, 2019 Buy$11.514,00046,0394,000Sep 10, 2019, 07:19 PM
Vig PamelaChief Scientific OfficerSep 06, 2019 Buy$10.971,61217,6821,612Sep 10, 2019, 07:17 PM
Peetz ChristopherPresident and CEOSep 09, 2019 Buy$11.144,32048,132196,570Sep 10, 2019, 07:11 PM
Peetz ChristopherPresident and CEOSep 06, 2019 Buy$10.914,75051,806192,250Sep 10, 2019, 07:11 PM
Fischer LaurentDirectorSep 06, 2019 Buy$10.711,72018,4291,720Sep 10, 2019, 07:10 PM
Fischer LaurentDirectorSep 10, 2019 Buy$10.299609,8814,650Sep 10, 2019, 07:10 PM
Fischer LaurentDirectorSep 09, 2019 Buy$10.661,97020,9923,690Sep 10, 2019, 07:10 PM
Walker Paul Edward10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:57 PM
Sonsini Peter W.10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:56 PM
SANDELL SCOTT D10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:56 PM
MOTT DAVID M10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:55 PM
MAKOWER JOSHUA10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:55 PM
Makhzoumi Mohamad10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:54 PM
Florence Anthony A. Jr.10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:54 PM
Chang Carmen10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:53 PM
Behbahani Ali10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:53 PM
BASKETT FOREST10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:52 PM
BARRIS PETER J10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:52 PM
New Enterprise Associates 16, L.P.10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0004,186,243Jul 24, 2019, 04:51 PM
Frazier Life Sciences IX, L.P.10% OwnerJul 22, 2019 Buy$15.00450,0006,750,0003,566,912Jul 24, 2019, 04:17 PM
O'Donnell NiallDirectorJul 22, 2019 Buy$15.00300,0004,500,0001,921,118Jul 24, 2019, 04:16 PM
Heron Patrick JDirectorJul 22, 2019 Buy$15.00450,0006,750,0003,566,912Jul 24, 2019, 04:12 PM
Flynn James E10% OwnerJul 22, 2019 Buy$15.00166,0002,490,000166,000Jul 24, 2019, 02:18 PM
Flynn James E10% OwnerJul 22, 2019 Buy$15.00166,0002,490,0001,724,456Jul 24, 2019, 02:18 PM
Novo Holdings A/S10% OwnerJul 22, 2019 Buy$15.00575,0008,625,0002,445,147Jul 23, 2019, 04:32 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
BJERKHOLT ERICCHIEF FINANCIAL OFFICER03/27/202449,600
Radovich PeterPRESIDENT AND COO03/25/2024111,017
Radovich PeterPRESIDENT AND COO01/09/202328,438
Vig PamelaCHIEF SCIENTIFIC OFFICER01/09/202328,438
Longpre LaraCHIEF DEVELOPMENT OFFICER09/10/201910,268
Longpre LaraCHIEF DEVELOPMENT OFFICER01/09/202320,684
Peetz ChristopherCHIEF EXECUTIVE OFFICER01/09/2023106,390
BJERKHOLT ERICCHIEF FINANCIAL OFFICER03/18/202451,600
Vig PamelaCHIEF SCIENTIFIC OFFICER02/02/202431,797
Longpre LaraCHIEF DEVELOPMENT OFFICER02/02/202422,184
Radovich PeterPRESIDENT AND COO02/02/202446,883
Peetz ChristopherCHIEF EXECUTIVE OFFICER02/02/2024157,491
Howe JolandaSVP, GLOBAL CONTROLLER02/02/202419,251
Radovich PeterCHIEF OPERATING OFFICER01/08/202439,473
Longpre LaraCHIEF DEVELOPMENT OFFICER01/08/202428,568
Vig PamelaHEAD OF RESEARCH & DEVELOPMENT01/08/202439,472
Peetz ChristopherPRESIDENT AND CEO01/08/2024146,033
Howe JolandaSVP, GLOBAL CONTROLLER01/08/202414,803
Howe JolandaSVP, Global Controller12/05/20237,350
Howe JolandaSVP, Global Controller12/05/202381,000
Vig PamelaHead of Research & Development11/10/202311,745
Longpre LaraChief Development Officer11/10/20239,673
Radovich PeterChief Operating Officer11/10/20234,859
Heron Patrick JDirector11/09/202382,353
Heron Patrick JDirector09/13/202381,425
GREY MICHAEL GDirector09/14/202341,738
GREY MICHAEL GDirector09/13/20231,151
GREY MICHAEL GDirector09/14/2023454,912
GREY MICHAEL GDirector09/13/202312,544
BJERKHOLT ERICChief Financial Officer09/11/2023296,492
Heron Patrick JDirector08/31/20233,884,764
Howe JolandaSVP, Global Controller08/25/202390,743
Radovich PeterChief Operating Officer07/03/202336,546
Longpre LaraChief Development Officer07/03/202325,749
Vig PamelaHead of Research & Development07/03/202336,546
Howe JolandaSVP, Global Controller07/03/202323,467
Peetz ChristopherPresident and CEO07/03/2023141,005
GREY MICHAEL GDirector06/08/202342,889
GREY MICHAEL GDirector06/08/2023423,632
Vig PamelaHead of Research & Development05/10/202311,576
GREY MICHAEL GDirector05/03/202342,889
GREY MICHAEL GDirector05/03/2023409,024
O'Donnell NiallDirector11/15/20221,846,022
O'Donnell NiallDirector11/14/2022629,423
O'Donnell NiallDirector11/11/20223,481,410
Clements IanChief Financial Officer11/10/20225,542
Peetz ChristopherPresident and CEO11/10/2022835
Vig PamelaHead of Research & Development11/10/202211,254
Radovich PeterChief Operating Officer11/10/20224,979
Longpre LaraChief Development Officer11/10/20221,398
Flynn James E10% Owner06/06/2022505,460
Flynn James E10% Owner06/06/2022456,795
Radovich PeterChief Operating Officer05/10/202215,859
Longpre LaraChief Development Officer05/10/202219,725
Vig PamelaHead of Research & Development05/10/202210,948
Peetz ChristopherPresident and CEO05/10/202220,349
Clements IanChief Financial Officer05/10/202215,262
Clements IanChief Financial Officer11/26/202110,425
Clements IanChief Financial Officer11/24/202110,080
Peetz ChristopherPresident and CEO11/24/2021100,800
Vig PamelaChief Scientific Officer11/10/202110,380
Tucker Edwin JonathanChief Medical Officer11/10/2021946
Radovich PeterChief Operating Officer11/10/202112,947
Longpre LaraChief Development Officer11/10/202110,177
Clements IanChief Financial Officer11/10/20216,190
Peetz ChristopherPresident and CEO10/01/202170,708
Vig PamelaChief Scientific Officer10/01/202126,265
Clements IanChief Financial Officer10/01/202130,309
Longpre LaraChief Development Officer10/01/202118,505
Radovich PeterChief Operating Officer10/01/202126,265
Tucker Edwin JonathanChief Medical Officer10/01/202126,265
Flynn James E10% Owner07/09/20211,570,328
Flynn James E10% Owner07/07/2021108,496
Flynn James E10% Owner07/06/2021797,426
Flynn James E10% Owner07/02/2021180,300
Tucker Edwin JonathanChief Medical Officer05/10/202121,681
Radovich PeterChief Operating Officer05/10/202114,708
Peetz ChristopherPresident and CEO05/10/202121,243
Longpre LaraChief Development Officer05/10/202118,407
Clements IanChief Financial Officer12/23/202029,691
Tucker Edwin JonathanChief Medical Officer03/05/20218,331
Tucker Edwin JonathanChief Medical Officer12/28/202032,086
Clements IanChief Financial Officer12/23/202045,975
Peetz ChristopherPresident and CEO12/23/202093,480
Vig PamelaChief Scientific Officer11/10/20209,083
Radovich PeterChief Operating Officer11/10/202013,144
Longpre LaraChief Development Officer11/10/202012,549
Tucker Edwin JonathanChief Medical Officer11/10/202019,464
Clements IanChief Financial Officer11/10/202020,930
Peetz ChristopherPresident and CEO11/10/202020,930
Tucker Edwin JonathanChief Medical Officer10/30/2020192,500
Tucker Edwin JonathanChief Medical Officer03/20/202029,740
Tucker Edwin JonathanChief Medical Officer03/19/202019,818
Fischer LaurentDirector09/17/201915,435
Fischer LaurentDirector09/16/20194,280
Brege LauraDirector09/10/2019112,200
Clements IanSVP Finance & Communications09/06/201946,039
Vig PamelaChief Scientific Officer09/06/201917,682
Peetz ChristopherPresident and CEO09/09/201948,132
Peetz ChristopherPresident and CEO09/06/201951,806
Fischer LaurentDirector09/06/201918,429
Fischer LaurentDirector09/10/20199,881
Fischer LaurentDirector09/09/201920,992
Walker Paul Edward10% Owner07/22/20196,750,000
Sonsini Peter W.10% Owner07/22/20196,750,000
SANDELL SCOTT D10% Owner07/22/20196,750,000
MOTT DAVID M10% Owner07/22/20196,750,000
MAKOWER JOSHUA10% Owner07/22/20196,750,000
Makhzoumi Mohamad10% Owner07/22/20196,750,000
Florence Anthony A. Jr.10% Owner07/22/20196,750,000
Chang Carmen10% Owner07/22/20196,750,000
Behbahani Ali10% Owner07/22/20196,750,000
BASKETT FOREST10% Owner07/22/20196,750,000
BARRIS PETER J10% Owner07/22/20196,750,000
New Enterprise Associates 16, L.P.10% Owner07/22/20196,750,000
Frazier Life Sciences IX, L.P.10% Owner07/22/20196,750,000
O'Donnell NiallDirector07/22/20194,500,000
Heron Patrick JDirector07/22/20196,750,000
Flynn James E10% Owner07/22/20192,490,000
Flynn James E10% Owner07/22/20192,490,000
Novo Holdings A/S10% Owner07/22/20198,625,000
Load More Insider Transactions
FUNDS WITH A POSITION IN MIRUM PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.2,461,7500.00185%16.48%Other
GEODE CAPITAL MANAGEMENT, LLC681,1800.0021%18.45%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.575,0000.04%-13.53%Other
BAKER BROS. ADVISORS LP190,4760.06%No changeOther
PALO ALTO INVESTORS LP64,7000.17%No changeOther
RENAISSANCE TECHNOLOGIES LLC58,6480.00268%-14.63%Other
UBS OCONNOR LLC49,9120.11%-18.18%Value
ALPS ADVISORS INC31,6790.00735%NewOther
D. E. SHAW & CO., INC.22,1780.00057%-4.91%Other
AQR CAPITAL MANAGEMENT LLC12,8760.00072%-17.16%Other
CHANGE IN SHARES OUTSTANDING FOR MIRUM PHARMACEUTICALS INC
STOCK BUYBACKS FOR MIRUM PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
13.44%
1Q
12/31/2023
06/30/2023
22.34%
2Q
12/31/2023
03/31/2023
23.75%
3Q
12/31/2023
12/31/2022
24.48%
4Q
12/31/2023
09/30/2022
33.48%
5Q
12/31/2023
06/30/2022
44.88%
6Q
12/31/2023
03/31/2022
48.97%
7Q
12/31/2023
12/31/2021
52.67%
8Q
12/31/2023
09/30/2021
53.52%
9Q
12/31/2023
06/30/2021
53.99%
10Q
12/31/2023
03/31/2021
54.86%
11Q
12/31/2023
12/31/2020
78.54%
12Q
12/31/2023
09/30/2020
85.50%
13Q
12/31/2023
06/30/2020
86.07%
14Q
12/31/2023
03/31/2020
88.71%
15Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
13.44%
1Q
06/30/2023
22.34%
2Q
03/31/2023
23.75%
3Q
12/31/2022
24.48%
4Q
09/30/2022
33.48%
5Q
06/30/2022
44.88%
6Q
03/31/2022
48.97%
7Q
12/31/2021
52.67%
8Q
09/30/2021
53.52%
9Q
06/30/2021
53.99%
10Q
03/31/2021
54.86%
11Q
12/31/2020
78.54%
12Q
09/30/2020
85.50%
13Q
06/30/2020
86.07%
14Q
03/31/2020
88.71%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MIRUM PHARMACEUTICALS INC
LOADING...